Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Zhongtai Pharmaceutical is a specialized Chinese pharmaceutical manufacturer focused on the production of biochemical active pharmaceutical ingredients (APIs) and finished drug products. The company is a leading producer of animal-derived hormones and enzymes, including oxytocin, pituitrin, chymotrypsin, and pepsin. Operating out of Harbin, it maintains large-scale manufacturing facilities compliant with Good Manufacturing Practice (GMP) standards to serve both domestic and global markets. Its product portfolio primarily supports therapeutic areas such as obstetrics, gynecology, and gastroenterology. As a subsidiary of the Harbin Pharmaceutical Group, the company leverages significant industrial resources to maintain its position as a high-tech enterprise in the biochemical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Zhongtai Pharmaceutical.